Terms: = Breast cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Diagnosis
23 results:
1. Thiosemicarbazide Derivatives Targeting Human TopoIIα and IDO-1 as Small-Molecule Drug Candidates for breast cancer Treatment.
Kaproń B; Czarnomysy R; Radomska D; Bielawski K; Plech T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982886
[TBL] [Abstract] [Full Text] [Related]
2. Noninvasive Evaluation of Multidrug Resistance via Imaging of abcg2/bcrp Multidrug Transporter in Lung cancer Xenograft Models.
Li C; Yang Q; Chen Z; Qiu Y; Du Y; Wang R; He Q; Yang J; Zhen H; Kang L
Mol Pharm; 2022 Oct; 19(10):3521-3529. PubMed ID: 35427142
[TBL] [Abstract] [Full Text] [Related]
3. Drug Resistance in Metastatic breast cancer: Tumor Targeted Nanomedicine to the Rescue.
Gote V; Nookala AR; Bolla PK; Pal D
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925129
[TBL] [Abstract] [Full Text] [Related]
4. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
Ring A; Kaur P; Lang JE
BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
[TBL] [Abstract] [Full Text] [Related]
5. breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes.
Wang L; Simons DL; Lu X; Tu TY; Avalos C; Chang AY; Dirbas FM; Yim JH; Waisman J; Lee PP
EBioMedicine; 2020 Feb; 52():102631. PubMed ID: 31981982
[TBL] [Abstract] [Full Text] [Related]
6. breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy.
Jendželovský R; Jendželovská Z; Kuchárová B; Fedoročko P
Biomed Pharmacother; 2019 Jan; 109():2173-2181. PubMed ID: 30551474
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of Amino Acid/Drug Transporters for Renal Transport of [
Ono M; Baden A; Okudaira H; Kobayashi M; Kawai K; Oka S; Yoshimura H
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754421
[TBL] [Abstract] [Full Text] [Related]
8. Role of preoperative breast MRI in ductal carcinoma in situ for prediction of the presence and assessment of the extent of occult invasive component.
Nori J; Meattini I; Giannotti E; Abdulcadir D; Mariscotti G; Calabrese M; Angelino F; Chiesa F; Saieva C; Vanzi E; Boeri C; Bianchi S; Sanchez L; Orzalesi L; Casella D; Susini T; Livi L
Breast J; 2014; 20(3):243-8. PubMed ID: 24750509
[TBL] [Abstract] [Full Text] [Related]
9. Inactivation of PTEN increases abcg2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia.
Huang FF; Wu DS; Zhang L; Yu YH; Yuan XY; Li WJ; Chen XP; Zhao XL; Chen FP; Zeng H
Cancer Lett; 2013 Aug; 336(1):96-105. PubMed ID: 23603434
[TBL] [Abstract] [Full Text] [Related]
10. breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.
Agarwal S; Hartz AM; Elmquist WF; Bauer B
Curr Pharm Des; 2011; 17(26):2793-802. PubMed ID: 21827403
[TBL] [Abstract] [Full Text] [Related]
11. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.
Shi C; Tian R; Wang M; Wang X; Jiang J; Zhang Z; Li X; He Z; Gong W; Qin R
Cancer Biol Ther; 2010 Dec; 10(11):1182-90. PubMed ID: 20948317
[TBL] [Abstract] [Full Text] [Related]
12. Comparison between 99mTc-sestamibi scintimammography and X-ray mammography in the characterization of clusters of microcalcifications: a prospective long-term study.
Grosso M; Chiacchio S; Bianchi F; Traino C; Marini C; Cilotti A; Manca G; Volterrani D; Roncella M; Rampin L; Marzola MC; Rubello D; Mariani G
Anticancer Res; 2009 Oct; 29(10):4251-7. PubMed ID: 19846982
[TBL] [Abstract] [Full Text] [Related]
13. Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population.
Østergaard M; Ernst A; Labouriau R; Dagiliené E; Krarup HB; Christensen M; Thorsgaard N; Jacobsen BA; Tage-Jensen U; Overvad K; Autrup H; Andersen V
Scand J Gastroenterol; 2009; 44(1):65-73. PubMed ID: 18819034
[TBL] [Abstract] [Full Text] [Related]
14. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (bcrp) genes and clinical outcome in childhood acute lymphoblastic leukemia.
Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
[TBL] [Abstract] [Full Text] [Related]
15. bcrp gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma.
Hu LL; Wang XX; Chen X; Chang J; Li C; Zhang Y; Yang J; Jiang W; Zhuang SM
Carcinogenesis; 2007 Aug; 28(8):1740-4. PubMed ID: 17494054
[TBL] [Abstract] [Full Text] [Related]
16. Drug resistance in renal tumors of childhood.
Ramachandran C
Curr Pharm Biotechnol; 2007 Apr; 8(2):99-104. PubMed ID: 17430158
[TBL] [Abstract] [Full Text] [Related]
17. Accuracy rates of US-guided vacuum-assisted breast biopsy.
Bonifacino A; Petrocelli V; Pisani T; Giannerini S; Giovagnoli A; Vecchione A; Mingazzini PL; Giovagnoli MR
Anticancer Res; 2005; 25(3c):2465-70. PubMed ID: 16080477
[TBL] [Abstract] [Full Text] [Related]
18. Multidrug resistance in hematological malignancy.
Hirose M; Hosoi E; Hamano S; Jalili A
J Med Invest; 2003 Aug; 50(3-4):126-35. PubMed ID: 13678381
[TBL] [Abstract] [Full Text] [Related]
19. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
van der Pol MA; Broxterman HJ; Pater JM; Feller N; van der Maas M; Weijers GW; Scheffer GL; Allen JD; Scheper RJ; van Loevezijn A; Ossenkoppele GJ; Schuurhuis GJ
Haematologica; 2003 Feb; 88(2):134-47. PubMed ID: 12604403
[TBL] [Abstract] [Full Text] [Related]
20. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
[TBL] [Abstract] [Full Text] [Related]
[Next]